W. Kimryn Rathmell
-
New Drugs on the Horizon sessions offer first disclosures of novel agents
Investigators in three related sessions shared details about 12 small molecules and biologics in or about to be tested in phase I clinical trials.
Investigators in three related sessions shared details about 12 small molecules and biologics in or about to be tested in phase I clinical trials.